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Abstract: Nonadherence to topical treatment of psoriasis is a common cause of treatment failure. 
This focus group study was conducted to obtain the patients’ own experiences and explanations 
regarding medical adherence. The participants consisted of eight primary adherent patients with 
moderate psoriasis treated with corticosteroid or corticosteroid–calcipotriol combinations, purpose-
fully sampled by age and sex at a dermatology outpatient clinic. Secondary medical adherence was 
supported by accessibility of the prescribing physician, the prescriber taking time to listen, having a 
more manageable disease, using a nonstaining product, and establishing routines around treatment 
at home. Secondary medical adherence was affected negatively by changes in daily routines, if the 
treatment influenced the patient’s sexual life, having too little time in the consultation room, lack of 
confidence in the prescriber, diverging information from health care personnel, experiencing side 
effects, having fear of side effects, impractical formulations of topical products, and impatience 
regarding time before an effect of the treatment was observed. From this study, the recommenda-
tions for the prescribing doctor to improve medical adherence are, the doctor needs to take time 
to listen to the patient, prescribe a topical product that is easy to apply and less greasy, inform 
the patients about benefits from treatments, and explain the rationale behind the treatment plan.
Keywords: psoriasis, adherence, corticosteroids, calcipotriol, focus groups
Introduction
Psoriasis is a chronic disease with a prevalence rate of 2%–4% in the Western popula-
tion.1 Topical corticosteroids and corticosteroid–calcipotriol combinations constitute 
first line of treatment. In chronic diseases, one of the main causes of treatment failure 
is medical nonadherence.2 In patients with psoriasis, the rate of medical nonadherence 
to topically prescribed corticosteroids or corticosteroid combinations is reported to 
range from 8% to 88%,3,4 addressed in studies using heterogeneous study designs. 
The multifactorial determinants of medical nonadherence to topical corticosteroids 
and corticosteroid/calcipotriol combinations have mainly been investigated in survey 
studies,5,6 while only briefly described in qualitative studies.7,8 This led us to conduct 
this study, to get the patients’ own experiences and explanations on medical adherence.
Participants and methods
In January 2016, we led two semistructured focus groups using open-ended questions in 
patients diagnosed with psoriasis and treated with topical corticosteroid and/or cortico-
steroid–calcipotriol combinations. Participants were purposefully sampled by age and sex 
at the outpatient clinic at the Department of Dermatology and Allergy Centre, Odense, in 
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Psoriasis patients’ experiences in topically treated psoriasis
December 2015. Upon recruitment, a Psoriasis Area Severity 
Index score and a Dermatology Life Quality Index score were 
obtained for each patient. Furthermore, patients were asked if 
they were primary adherent, ie, having filled their prescription, 
and provided a measure of self-reported secondary adherence, 
ie, not applying medication from filled prescription, on a visual 
analog scale. Finally, patients were asked open questions regard-
ing their living/health conditions and use of antipsoriatic treat-
ments (medical history and sociodemographic characteristics 
of patients are presented in Tables 1 and 2).
One focus group was held for men and another for 
women. The study was conducted in accordance with the 
World Medical Association’s Declaration of Helsinki. Eight 
primary adherent patients suffering from psoriasis took part 
in the study, five men and three women. The age range was 
20–66 years, with a median age of 43.5 years. The focus 
groups were led by MTS and HJ in a conference room at 
the hospital. To demonstrate primary adherence, the patients 
were asked to bring all the packages of corticosteroids and 
 corticosteroid–calcipotriol combinations they had at home. 
Initially, while placing the packages on the table in front of 
them, the patients were briefly asked to introduce themselves 
and tell about their disease and use of topical antipsoriatics. 
After this, we continued to discuss reasons for medical non-
adherence. The discussions were grouped in five consecutive 
sections according to the determinants of nonadherence 
defined by the World Health Organization (WHO)9 listed 
in Table 3. We used audio recording and continued until all 
points were discussed. Each focus group lasted ~100 minutes.
The audio records were transcribed and thereafter manu-
ally coded by MTS. In the evaluation, we used deductive 
qualitative content analyses based on WHO’s five categories 
for determinants affecting adherence. Codes were grouped 
into larger categories. Uniformities and variations were 
revealed by MTS and HJ in a comparative process.
Ethics
Ethical approval was not required for this study according 
to Danish law. A signed consent was obtained from all par-
ticipants before the focus groups were held.
Results
All reported determinants influencing medical adherence are 
given in Tables 4 and 5. Medical adherence was  supported 
by living with a partner, accessibility of the prescribing 
physician, the prescriber taking time to listen, having a 
more manageable disease, using a nonstaining product, and 
establishing routines around treatment at home (Table 4). 
In contrast, medical adherence was negatively affected by 
changes in daily routines, if the treatment influenced the 
patient’s sexual life, having too little time in the  consultation 
room, lack of confidence in the prescriber, diverging informa-
tion from health care personnel, experiencing side effects, 
having fear of side effects, impractical formulations of topical 
products, and impatience regarding time before an effect of 
the treatment was observed (Table 5). The price of medica-
tion was considered high, but the participants prioritized to 
buy the medication or had the medication paid for by health 
insurance or family members. Although some of the patients 
expressed a wish for an effective treatment, they also reported 
discontinuing treatment when it worked. Six out of eight 
patients used complementary approaches as a supplement 
to prescribed treatments; most commonly sun bathing and 
vitamin supplements (Table 6).
Discussion
This study adds information on important aspects of living 
with psoriasis, a disease requiring topical treatment that is 
both time consuming and impractical for the patient. Using 
a qualitative research design helped us to provide insight 
into the nonmeasurable aspects of the patient’s perceptions 
on medical drugs and daily life. The results from our study 
may not be representative of all patients with psoriasis. This 
is stressed by the patients described in this study all being 
primary adherent and having regular checkups at the hospital 
clinic. To identify differences in determinants of nonadher-
ence between primary versus secondary nonadherent patients, 
we recommend future studies to be conducted among 
topically treated primary nonadherent psoriasis patients. 
Potentially, participants could also be sampled from other 
settings, ie, general practice or private dermatologists. The 
study findings align with those reported in the international 
literature. In relation to social/economic factors, adherence 
was limited when patients experienced the disease influencing 
on their intimate life,10 but improved by receiving support 
from their partner.3 Considering treatment factors, adher-
ence was limited when patients experienced the treatment as 
greasy,5 but improved when treatment was easy to apply.5,11 
In relation to the health care system, adherence was limited 
when patients experienced uncertainty regarding the rationale 
Table 3 Determinants of nonadherence defined by the World 
Health Organization (WHO)9
1. Social-economic 
2. Health care-related 
3. Disease-related 
4. Treatment-related 
5. Patient-related 
Note: Reprinted by permission from WHO  [Report No: WHO/MNC/03.01]. 
Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health 
Organization; 2003. © 2003 WHO.9
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Table 4 Key categories and property codes relevant to being adherent to prescribed topical corticosteroids and corticosteroid–
calcipotriol combinations
Key category Property code (characteristics) Illustrative data extract
Social/economic Being married/cohabitation
Apply treatment before major social events
Routines of everyday life
Not paying for medication
Reducing stress 
“My wife encourages me to apply the cream.” Jonah
“My wife checks my skin for flare-ups, because I don’t.” Jake
“I apply the gel more carefully if I need to go somewhere.” Kimberly
“It’s more comfortable if I look good when we’re going out.” Jake
“When I’m going on a date, I’m concerned about my psoriasis.” Romeo
“Habits and rituals help me […] If I bring the gel with me to the swimming pool 
I will remember to use it.” Kimberly
“I worked on an oil rig; it was a daily routine. As long as I was there, I used the 
cream every day.” Charlotte
“I get a lot of prescription subsidies so it’s not expensive.” Mike
“My parents pay for the cream.” Arthur
“I get so much prescribed medication that I actually get the expenses covered 
by the health insurance.” Kimberly
“I try to relax and have less to think of […] stressing less reduces my flare-ups.” 
Melinda
Health care-related Confidence in prescriber
The prescriber takes time to listen
Writing down questions for the consultations
“When a doctor writes a prescription, I’m confident in the medical authorities; I 
redeem the prescription and use the medication.” Jake
“I have good confidence in doctors […] there must be good reasons why the 
doctors say what they say.” Arthur
“They ask.” Jake
“It seems that the doctors have time for their patients […] maybe it takes half 
an hour per patient.” Jonah
“It’s important to write down a list of questions to bring to the consultation 
[…] If I have any questions, I always write them down.” Kimberly
Disease-related Severity of disease
Duration of disease
Psoriasis affected visible areas
“If I get a flare-up, then I’ll do something about it.” Jake
“I will apply more cream if it gets really bad.” Melinda
“The worse it gets, the more you follow the treatment plan.” Jonah
“I’m not afraid of the side effects, because I’ve used the cream for many years […] 
when I was a child, my mother used to apply steroid creams on me.” Charlotte
“I use more cream if my psoriasis starts to flake […] I use more cream where 
the skin can be peeled off in flakes.” Jake
Treatment-related Drug formulation in liniment
Use equipment that eases topical application
Uncertain if the doctor’s treatment plan is 
not followed
“It’s amazing how the liniment doesn’t grease and it works well […] Liniment… 
it’s the one I prefer to use, because it doesn’t turn my hair greasy.” Mike
“The radiator brush is very good. The angle makes it easier to apply.” Kimberly
“The gel applicator is amazing and easy to put in my toilet bag […] I started 
using a bath brush to help apply the cream.” Charlotte
“The treatment plan from the doctor says ‘follow your doctor’s instructions’ 
[…] It doesn’t say what happens if you don’t follow it.” Jonah
Patient-related Setting routines around home treatments
Vanity
“I make it part of my daily routine.” Melinda
“In the bathroom, I have a small closet and a shelf with all my remedies.” 
Charlotte
“It’s my vanity.” Melinda
Table 5 Key categories and property codes relevant to being nonadherent to prescribed topical corticosteroids and corticosteroid–
calcipotriol combinations
Key category Property code (characteristics) Illustrative data extract
Social/
economic
Changing routines
Being at work
Treatment influences on sexual life
Price of treatment
“I occasionally forget to put the cream on in the weekends.” Charlotte
“If I’m out visiting a mate, I sometimes forget to put the cream on.” Arthur
“In the weekends I tend to forget, because other events occur.” Kimberly
“I treat my skin in the morning before I leave and in the evening when I get home.” Mike
“It’s not possible to put the cream on at work […] There are no toilets in a lot of the 
places I work.” Jonah
“I don’t feel so attractive when I’m all greased in ointment.” Charlotte
“I couldn’t have bought the ointment if my parents didn’t pay for it […] It had become 
so expensive.” Melinda
(Continued)
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Key category Property code (characteristics) Illustrative data extract
Health care-
related 
Lack of information from prescriber
Lack of confidence in prescriber
Need for a patient-centered treatment
Lack of immediate access to the 
dermatologist
Lack of uniform information from 
prescribers, pharmacologists, and 
Patient’s Information Leaflet 
“After I got handed a bunch of cream with no details on how to use them I totally lost 
the trust in doctors.” Arthur
“So regarding the ointment, I was just told it was the only one available […] Liniments 
work better for me, but I’m always prescribed an ointment or a cream.” Melinda
“I realized that the doctors were not open to other treatment options.”  Charlotte
“I started to doubt the doctors.” Mike
“The doctor’s treatment plans are too similar compared to the diversity of the disease.” 
Jake 
“You cannot contact the dermatologist by phone, unless you have time to wait an hour 
for someone to pick up the phone.” Jonah
“It’s difficult to get in touch with the dermatologists.” Kimberly
“If there’s a month left till your next check-up is due, you may end up not following the 
doctor’s treatment plan.” Melinda
“The pharmacologist told me to put a thin layer whilst the dermatologist told me to 
apply a thick layer […] If you read the Patient’s Information Leaflet, you’ll get different 
information than what you’ll get informed from the dermatologist.” Melinda
Disease-
related
Little extent of disease
Psoriasis being a chronic disease
Affected areas difficult to reach by hand
“I don’t necessarily use the cream if I don’t have a psoriasis flare-up […] If I’m not 
bothered, then why should I apply the cream? […] If it doesn’t itch, then why should I 
treat it!” Jake
“I tend to give up when I experience a new flare-up.” Romeo
“It’s something that never disappears completely […] You won’t suddenly become 
cured.” Jonah
“If I can’t reach the parts of my body that are affected, then I won’t get it treated.” Mike
“Sometimes I don’t treat the small areas in the back, because it’s difficult to reach.” 
Jonah
“It’s difficult to reach the psoriasis on my back, flexor side of my lower legs and scalp.” 
Charlotte
Treatment-
related
Side effects
Greasiness 
Drug formulation in ointment
Stop treatment when there has been 
effect from treatment
“I’m aware of the scary side-effect that causes the skin to get thinner.” Jake
“A week has gone by and my skin has been treated; now my skin has gone thinner.” 
Mike
“I have used ointments containing cortisone for 25-30 years and now I have skin 
atrophy.” Charlotte
“For me it’s a constrain to be all creamed up; I stain everything with cream all over the 
place.” Arthur
“When I apply the ointment it greases a lot […] You can clearly see when I have the 
ointment on; it greases a lot and I leave stains.” Romeo
“My skin itches a lot under the occluding ointment […] Sometimes it’s worse when I 
apply a thick layer of ointment.” Kimberly
“The ointment doesn’t absorb into the skin.” Charlotte
“If I apply the ointment two times and the psoriasis is gone, I don’t apply it again.” Jake
“If it works well, I lose my motivation.” Charlotte
“If it goes well, I tend to stop.” Jonah
Patient-related Negative attitude toward 
corticosteroids
Forgetfulness
Intentionally rejecting treatment 
Pregnancy and lactation
Fearful of side effects
Impatient regarding time before 
treatment works
“There are no healthy ingredients in those creams.” Mike
“They’re definitely not good for the body.” Arthur
“Once in a while I forget to apply the cream […] Even when I decide to treat my skin 
for a period of time, I still forget.” Romeo
“I intentionally refused to follow the doctor’s treatment plan.” Jake
“I would rather not have it […] I prefer my moisturizers.” Jonah
“I didn’t apply the cream to be on the safe side […] When I was pregnant and 
breastfeeding, I didn’t apply the cream.” Kimberly
“I’m seriously scared of the side effects.” Jonah
“I’m aware that it has an effect on my body.” Arthur
“As time goes by, I lose my patience.” Arthur
“It’s probably just me who doesn’t have patience.” Kimberly
Table 5 (Continued)
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behind the treatment plan,6,7,12 but improved from confidence 
in the prescriber.6 In relation to the disease, adherence was 
limited by having areas difficult to reach,6 but improved 
when suffering from widespread disease.6 In relation to 
the patients themselves, adherence was limited by patients 
terminating treatment when initial positive treatment results 
were reached,5 but improved by establishing routines in their 
everyday life.5,12 In addition to previous research, this study 
showed that the patients received help from their partner in 
checking the skin for flare-ups and assisting in greasing.
Treatments need to be continued after they have shown 
an initial beneficial effect. Further research is needed to 
elucidate the effect of, eg, early follow-up visits13 or use 
of technical support on adherence. Technical support 
could include sending mobile phone reminders14 or use of 
 patient-supporting apps delivered by smartphones. For the 
prescriber to help improve adherence, the recommendations 
from this study are the doctor needs to take time to listen to 
the patient, prescribe a topical product that is easy to apply 
and less greasy, inform the patients about benefits from treat-
ments, and explain the rationale behind the treatment plan.
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Table 6 Complementary treatments used
Complementary 
treatments used
Property code 
(characteristics)
Illustrative data extracts
Outdoor tanning Travels to the south “Sun and sea […] I bought a small apartment in Spain close to the beach.” Charlotte 
Using moisturizers (developed 
by nonmedical personnel)
Cream from ostrich feathers “I used a cream derived from ostrich feathers. It stank terribly.” Kimberly
Food supplements Aloe vera juice “I’ve been drinking Aloe Vera juice every day for half a year.” Charlotte
Vitamin extracts oral “I take some vitamins […] it helps.” Jonah
Omega-3 fish oil oral “My skin has become smoother after I started taking fish oil.” Charlotte
Flaxseed oil oral “I moisturize myself from within with flaxseed oil.” Jonah
“Yes flaxseed oil should be good for many things. I also use it.” Kimberly
Healthy food Avoiding meat products “I live healthy. Everything I eat is organic and I rarely eat meat.” Jonah
Vegetable juice “I drink juice, carrot juice.” Jonah
Salt baths “Usually I sit and wash my legs in a bowl of salt water.” Charlotte
Products with silica mud “I went to the Blue Lagoon in Iceland and bought Silica Mud.” Charlotte
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